This collection of evidence from smaller studies linking GBA mutation status to several clinical phenotypic characteristics including disease progression and survival in PD has implications for genetic counselling, clinical follow-up and stratification in future clinical trials. This evidence concerns the gene GBA1 and Parkinson disease.